OR AKIVA, Israel, June 5, 2017 /PRNewswire/ --
Expanding Orthopedics Inc. (EOI), a privately-held medical device company focused on developing and commercializing innovative expandable devices for spine surgery, today announced CE mark of the FLXfit™15, enhancing the already successful FLXfit™ 3D expandable cage. The FLXfit™15 expands up to 4mm and enables controlled lordosis correction of up to 15⁰. There are two linear length options; a 40mm and a 32mm version.
The higher range expansion will enable surgeons to better treat their patients and restore lordosis angle up to 15⁰. The 32mm length option will offer great flexibility in treating patients with smaller anatomies. The ability to deliver the largest, in-class, TLIF, expandable cage with 4mm height expansion and 15 degrees of lordosis correction through a small unilateral tube is a paradigm change in the MIS fusion market.
Ofer Bokobza, CEO of Expanding Orthopedics, commented "Expandable cages are gaining market momentum and play a key role in successful MIS fusion procedures. The FLXfit™ 3D expandable cage introduced a new paradigm with expandable cages and is already making a significant traction in the market place. We are thrilled with the release of the FLXfit™15 as it represents our continued commitment for innovation and ability to deliver state-of-the-art spine fusion solutions." He concluded, "We believe that the versatility of the new FLXfit™ family will help EOI gain a greater share in the fusion surgery market both in MIS and open approaches."
The FLXfit™15 is the subject of a pending 510k and is not available for sale in the US.
About Expanding Orthopedics Inc.
Expanding Orthopedics Inc. is medical device company developing and marketing innovative products designed to address unmet clinical needs for spine care and improve long-term patients' outcome. The Company is spearheaded by a seasoned management team, and is advised by a prominent team of spine surgeons. EOI owns a broad patent portfolio around anatomically fit, expandable devices for enhanced stability through a minimally invasive approach.
David Elkaim, VP Marketing and Sales